BBR and NF-κB specific inhibitor pyrrolidine dithiocarbamate (PDTC, 100 μM; Sigma, USA) pretreatment for 2 h obviously decreased the p65 content in the nucleus and increased this content in the cytoplasm under hyperglycemia condition. The gene discussed is NFKB1; the disease is Hyperglycemia.